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Ten bacteriophages were isolated from faeces and their lytic effects assayed on 103
pathogenic and non-pathogenic Enterobacteriaceae. Two phages (DT1 and DT6) were
selected based on their host ranges, and their lytic effects on pathogenic E. coli strains
inoculated on pieces of beef were determined. We evaluated the reductions of viable
cells of Escherichia coli O157:H7 and non-O157 Shiga toxigenic E. coli strains on meat
after exposure to DT6 at 5 and 24◦C for 3, 6, and 24h and the effect of both phages
against an enteropathogenic E. coli strain. Significant viable cell reductions, compared to
controls without phages, at both temperatures were observed, with the greatest decrease
taking place within the first hours of the assays. Reductions were also influenced by
phage concentration, being the highest concentrations, 1.7 × 1010 plaque forming units
per milliliter (PFU/mL) for DT1 and 1.4 × 1010 PFU/mL for DT6, the most effective. When
enteropathogenic E. coli and Shiga toxigenic E. coli (O157:H7) strains were tested,
we obtained viable cell reductions of 0.67 log (p = 0.01) and 0.77 log (p = 0.01) after
3 h incubation and 0.80 log (p = 0.01) and 1.15 log (p = 0.001) after 6 h. In contrast,
all nonpathogenic E. coli strains as well as other enterobacteria tested were resistant.
In addition, phage cocktail was evaluated on two strains and further reductions were
observed. However, E. coli bacteriophage insensitive mutants (BIMs) emerged in meat
assays. BIMs isolated from meat along with those isolated by using the secondary
culture method were tested to evaluate resistance phenotype stability and reversion. They
presented low emergence frequencies (6.5 × 10−7–1.8 × 10−6) and variable stability and
reversion. Results indicate that isolated phages were stable on storage, negative for all the
virulence factors assayed, presented lytic activity for different E. coli virotypes and could
be useful in reducing Shiga toxigenic E. coli and enteropathogenic E. coli viable cells in
meat products.
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INTRODUCTION
Shiga toxin-producing Escherichia coli (STEC) are human
pathogens that can cause diarrhea, as well as severe clinical mani-
festations including hemorrhagic enterocolitis, hemolytic uremic
syndrome (HUS), and thrombotic thrombocytopenic purpura
(Su and Brandt, 1995; Griffin et al., 2002; Yoon and Hovde,
2008). STEC produce several virulence factors which contribute
to their pathogenicity. Shiga toxins (Stx), AB type toxins that
inhibit protein synthesis in target cells, are the most characterized
virulence factors (Thorpe et al., 2002). Shiga toxins produced in
the intestines by STEC are able to enter the systemic circulation
causing severe damage to distal organs. The degree of damage
is related to the amount of toxin produced during the infection
(Ritchie et al., 2003). STEC synthesize two main types of Shiga
toxins encoded by stx1 and stx2 genes. Moreover, the enterocyte
attaching-and-effacing lesion gene (eaeA), which is also present in
enteropathogenic strains (EPEC), can contribute to the virulence
of STEC. The gene codes for the intimin protein, which allows
bacteria to attach themselves to the intestinal epithelium (Frankel
et al., 1998).
Foodborne disease-producing Enterobacteriaceae, such as
Shigella spp., Salmonella spp., EPEC and STEC, are important eti-
ologic agents of infantile gastroenteritis in Argentina (Binsztein
et al., 1999; Rivas et al., 2008). In developing countries, EPEC are
the cause of outbreaks of infantile diarrhea with high mortality in
children under two years of age. In Argentina, HUS is endemic,
with approximately 400 new cases being reported annually by
National Health Surveillance System (Rivas et al., 2006), andmore
than 7000 cases being reported since 1965 (NCASP, 1995). In
2005, the annual incidence of HUS is 13.9 cases/100,000 children
under five years of age (Rivas et al., 2006). Recent epidemiological
studies showed that there is a sustained global increase in the iso-
lation of non-O157 STEC strains from humans (Tozzi et al., 2003;
Brooks et al., 2005; Bettelheim, 2007) and animals (Jenkins et al.,
2003; Fernandez et al., 2009), particularly STEC of serogroups
O26, O103, and O111 (Ogura et al., 2007).
The therapeutic potential of bacteriophages has been explored
since they were discovered by Felix d’Herelle (Summers, 1999).
Some of the attributes that make bacteriophages interesting as
tools for biological control are: (i) their ability to infect and lyse
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specific bacterial target cells and their inability to infect eukary-
otic cells; (ii) phages generally do not cross bacterial species or
genus barriers, and therefore do not affect desirable microorgan-
isms commonly present in foods, the gastrointestinal tract or the
normal bacterial microbiota (Carlton et al., 2005); (iii) phages
need a bacterial host in which to multiply and therefore will per-
sist only as long as the sensitive host is present (Clark and March,
2006). The potential of bacteriophages to control food pathogens
is reflected in recent studies involving various pathogens includ-
ing Campylobacter jejuni (Atterbury et al., 2003; Bigwood et al.,
2008), E. coliO157:H7 (O’Flynn et al., 2004; Abuladze et al., 2008)
and Listeria monocytogenes (Leverentz et al., 2003; Guenther et al.,
2009; Holck and Berg, 2009). Several strategies are currently being
applied to preserve perishable refrigerated foods and extend their
shelf-life. However, physical processes and chemical compounds
(preservatives) used for this purpose may alter meat organoleptic
properties. Although bacteriophages represent a novel approach,
there are no reports of their industrial use to improve safety, even
if this “new, ecological, and specific” technology may be cheaper
than “older” technologies, since phages can be isolated from the
environment and are self-replicating entities. On the other hand,
their inclusion into a meat product can be seen as a less aggressive
approach.
The aim of this work was to isolate phages with specific lytic
capacity for E. coli strains in order to determine phage host range
and analyze their potential as biocontrol agents for STEC and
EPEC strains in beef products.
MATERIALS AND METHODS
BACTERIOPHAGE ISOLATION AND PREPARATION OF STOCKS
E. coli DH5α was used to isolate bacteriophages from fifty
stool samples of patients with diarrhea treated at the Centenary
Hospital, Rosario. This strain was grown up to an optical
absorbance of 1 (A600 = 1) in 10mL of Hershey broth (8 g/L
Bacto nutrient broth, 5 g/L Bacto peptone, 5 g/L NaCl, and 1 g/L
glucose) (Difco, Detroit, MI, USA) supplemented with MgSO4
(5mM) (Cicarelli, San Lorenzo, Santa Fe, Argentina). A por-
tion of faeces (5 g) was added and the culture was incubated
for a further 12 h at 37◦C. Next, chloroform (0.5mL, Cicarelli)
was added and the preparation was mixed and centrifuged at
15,000× g for 10min. The supernatant was then filtered through
a 0.45μm pore size (Gamafil S.A., Buenos Aires, Argentina)
(Kudva et al., 1999). Bacteriophage isolation and purification
were performed by the double-layer plaque technique (Balagué
et al., 2006). Briefly, aliquots of filtrates (10 and 100μL) were
mixed with 100μL of recipient strain culture (A600 = 1), three
mL of molten soft agar at 45◦C (Hershey broth supplemented
with 5mM MgSO4 and 0.7% agar) were added to each suspen-
sion and the mixture was poured onto pre-solidified Hershey agar
plates and incubated overnight at 37◦C. To isolate and purify
phages, well-defined single plaques on the soft agar were picked
and placed in 5mL of Hershey medium supplemented with 5mM
MgSO4. Tubes were kept at 4◦C for 2 h and then inoculated with
100μL of recipient strain culture (A600 = 1). Inoculated tubes
were incubated at 37◦C with intermittent shaking until com-
plete lysis. Next, chloroform (0.1mL) was added and cultures
were centrifuged at 4000× g for 10min. Phage stocks were stored
at 4◦C and enumerated by the double-layer plaque technique
(Jamalludeen et al., 2007). These steps were repeated three times.
Stability of phage stocks was evaluated after twomonths of storage
at 4◦C.
BACTERIOPHAGE AND BACTERIA CHARACTERIZATION
Phage electron micrographs were obtained by the procedure of
Bolondi et al. (1995). Phage suspensions were concentrated by
centrifugation (1 h, 70,000 × g, 5◦C) and subsequently stained
with phosphotungstic acid (2% w/v) (Biopack, Buenos Aires,
Argentina). Electron micrographs were obtained using a JEOL
1200 EX II electron microscope (INTA Castelar, Buenos Aires,
Argentina) operating at 85 kV. Phage morphologies and dimen-
sions (head diameter, tail length, and diameter) were recorded.
Phages and strains of E. coli were tested for the presence of
toxin-encoding genes (stx1, Shiga toxin 1; stx2, Shiga toxin 2;
eaeA, attaching-and effacing; LT1, thermolabile toxin and ST1,
thermostable toxin) of diarrheogenic E. coli by the polymerase
chain reaction (PCR) using primers detailed in Table 1 (Pass et al.,
2000). PCR conditions were as follows: initial denaturing step at
95◦C for 2min, followed by 25 cycles of 95◦C for 30 s, anneal-
ing at 63◦C for 30 s and elongation at 72◦C for 30 s, followed by
a final step at 72◦C for 5min to achieve complete product elon-
gation. E. coli ATCC43889 (stx2 and eaeA), ATCC43890 (stx1),
and ATCC43895 (stx1, stx2, and eaeA, and also harboring the
stx2 phage, 933W) were used as positive controls, while entero-
toxigenic E. coli ATCC35401 was used for LT1 and ST1 genes.
E. coli HB101 and ATCC98222 were utilized as negative controls.
Amplified products were resolved by electrophoresis using 3%
agarose gels in TBE buffer (89mM Tris borate, 2mM EDTA, pH
8.0) (Promega, Madison, WI, USA) at 100 V for 3 h. Gels were
stained with ethidium bromide (0.5μg/mL) (Sigma, St. Louis,
MO, USA) and PCR products were visualized under UV light.
BACTERIOPHAGE SPECIFICITY
The host range of each phage was determined by the dou-
ble layer agar technique using 44 strains isolated from stool
Table 1 | Sequences of primers used in this study.
Gene Primera Product size
(bp) expected
stx1 fp: 5′-ACGTTACAGCGTGTTGCRGGGATC-3′ 121
bp: 5′-TTGCCACAGACTGCGTCAGTRAGG-3′
stx2 fp: 5′-TGTGGCTGGGTTCGTTTATACGGC-3′ 102
bp: 5′-TCCGTTGTCATGGAAACCGTTGTC-3′
eaeA fp: 5′-TGAGCGGCTGGCATGATGCATAC-3′ 241
bp: 5′-TCGATCCCCATCGTCACCAGAGG-3′
LT1 fp: 5′-TGGATTCATCATGCACCACAAGG-3′ 360
bp: 5′-CCATTTCTCTTTTGCCTGCCATC-3′
ST1 fp: 5′-TTTCCCCTCTTTTAGTCAGTCAACTG-3′ 160
bp: 5′-GGCAGGACTACAACAAAGTTCACAG-3′
afp, forward primer; bp, backward primer. stxl and stx2: Shiga toxin1 and 2
encoding genes; eaeA: intimin encoding gene; LTl and STl: thermolabile and
thermostable toxins encoding genes.
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samples, and urine cultures (uropathogenic E. coli, UPEC).
Stool and urine samples were streaked in Cystine Lactose
Electrolyte Deficient (CLED) agar plates. Simmons citrate agar
test was performed on growing lactose positive colonies. After
incubation for 24 h at 35◦C, only lactose positive and cit-
rate negative colonies were further identified using API system
(Biomerieux, Bs. As., Argentina). Sixteen E. coli strain from
food (Balagué et al., 2006), one uropathogenic E. coli strain
(E. coli T149) which expresses fimbriae P and α-hemolysin
(Balagué et al., 2004) and five ATCC E. coli strains were
also tested (ATCC 43890; 43889; 43895; 35401 and 98222).
Previously characterized (API system) isolates from stool sam-
ples were also tested: Shigella flexneri, S. sonnei, Proteus mirabilis,
Citrobacter freundii, Klebsiella pneumoniae, Salmonella enteritidis,
Salmonella Typhi and Salmonella Typhimurium. Strains tested
against stock phages are listed in Table 2. Bacteriophage sen-
sitivity was assayed by placing 10μL of phage suspension on
the solidified soft-agar layer inoculated with 100μL of each
bacterial culture, incubated for 24 h at 37◦C, and the pres-
ence of lysis zones or plaques was examined (Goodridge et al.,
2003).
MEAT ASSAYS
Beef from cow hindquarter purchased from retail was asepti-
cally cut into pieces (1 cm2 of surface and 0.4 cm thick), placed
in petri dishes and pre-equilibrated to 5 or 24◦C. The required
pH was obtained by washing with sodium chloride-magnesium
sulfate (SM) buffer (0.05M TRIS, 0.1M NaCl, 0.008M MgSO4,
0.01% w/v gelatin, pH = 7.5) prior to inoculation with bacteria
and phage. Host strains employed in this study, namely non-
O157 STEC (ARG4827; serogroup O18; harboring stx1 and stx2
genes) (Balagué et al., 2006), O157:H7 STEC (464; harboring
stx1 and eaeA genes) and an EPEC (EPEC920; which harbors
Table 2 | Strains tested against stock phages.
Source Strains (amount) Strains characteristics/
description
Food Escherichia coli (10) 8 non-O157 STEC and
2 O157:H7 STEC
Stool sample Escherichia coli (9) 4 O157:H7 STEC and
5 EPEC
Escherichia coli (18) Non-pathogenic
Shigella spp. Other enterobacteria
Salmonella spp.
Proteus mirabilis
Citrobacter freundii
Klebsiella pneumoniae (17)
Urine culture Escherichia coli (17) UPEC
ATCC Escherichia coli (5) 35401; 43889; 43890;
43895 and 98222
EPEC, enteropathogenic E. coli; O157:H7 STEC, O157:H7 Shigatoxigenic E. coli;
non-O157 STEC, Shigatoxigenic non-O157 E. coli; UPEC, urophatogenic E. coli;
ATCC, american type culture collection.
eaeA gene), were grown in Hershey medium supplemented with
MgSO4 (5mM) for 12 h at 37◦C. Bacterial strains and specific
bacteriophages added to the meat samples are detailed in Table 3.
Twenty μL of each diluted bacterial suspension (ranging from
5.9 × 105 to 3.9 × 107 CFU/mL) were pipetted onto the surface
of each meat piece and allowed to attach for 10min at room
temperature. Another 20μL of each bacteriophage were then
pipetted on the meat, at low multiplicity of infection (MOI),
1.7 × 109 PFU/mL for DT1 and 1.4 × 109 PFU/mL for DT6, or
high MOI, 1.7 × 1010 PFU/mL for DT1 and 1.4 × 1010 PFU/mL
for DT6. Pieces of meat were also added with SM buffer (pH
7.5), instead of phage suspension, as controls. At 3, 6, and 24 h,
meat pieces were transferred to a sterile bag, 5mL SM buffer were
added and samples processed for 2min in a Stomacher (Seward,
London, UK). A 1mL portion of the stomacher fluid was trans-
ferred to a sterile tube and cells were pelleted by centrifugation
at 3000× g for 10min. The supernatant was removed and cells
were resuspended in 1mL SM buffer. Finally, a 0.1mL sample
was removed, serially diluted (102–104-fold) in SM buffer and
0.1mL volumes of each dilution were plated on Hershey agar
for viable cell enumeration (Bigwood et al., 2008). Phage cock-
tail (DT1 and DT6 in equal proportions) was assayed on E. coli
DH5α (indicator strain used for phage isolation) and in O157:H7
STEC (464) using the methodology employed for each indi-
vidual phage described above. Three replicates were performed
for each treatment and one meat piece processed for replicate.
Uninoculated controls were tested to determine the presence of
naturally occurring bacteriophages. Plaques (PFU/mL) were eval-
uated by the double layer agar technique (Jamalludeen et al.,
2007).
BACTERIOPHAGE INSENSITIVE MUTANTS (BIMs) ISOLATION
Bacteriophage insensitive mutants (BIMs) were isolated by the
secondary culture method described by Guglielmotti et al. (2007)
with somemodifications. E. coli sensitive strains (one EPEC, three
O157:H7 STEC and one non-O157 STEC) (A600 = 0.2 − 0.3)
were infected with a phage suspension at different infection ratios
(multiplicity of infection, MOI of ≈ 10 and 1), incubated in
Hershey broth at 37◦C for 24 h and observed visually until com-
plete lysis. An uninfected culture of each E. coli strain was used as
a control. Cultures exhibiting complete and delayed lysis were the
best candidates to isolate BIMs. After lysis, further incubation for
48 h at 37◦C was required for secondary growth. Each tube with
secondary growth was spread on Hershey agar plates for colony
isolation.
BIMs were isolated from meat as described in meat assays
methodology described above modified with an extended incu-
bation time (48 h) at 37◦C. For both of the aforementioned
methodologies, after incubation of agar plates, eight different
colonies were randomly isolated (on agar plates) and cultured
overnight in Hershey broth at 37◦C. These isolates were puri-
fied by three consecutive streakings on Hershey agar plates. The
growing colonies were isolated as presumptive BIMs.
BIMs CONFIRMATION
Presumptive BIMs were confirmed by a liquid culture sensitiv-
ity test (Guglielmotti et al., 2007). Briefly, a log-phase culture
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Table 3 | E. coli viable cell logarithmic reductions after phage treatment of contaminated meat products.
Phage stock/sensitive strain Assay conditions Log reduction in E. coli viable cellsa
after the incubation time (h)b
T (◦C) MOI 3 6 24
DT1/EPEC (920) 5 4.4 × 102 NS **0.80 ± 0.14 NS
24 4.8 × 102 **0.30 ± 0.05 NS NS
5 4.4 × 101 NS **0.49 ± 0.09 NS
24 4.8 × 101 NS NS **0.46 ± 0.08
DT6/EPEC (920) 5 5.2 × 102 **0.67 ± 0.12 **0.59 ± 0.11 *0.46 ± 0.15
24 6.5 × 103 *0.32 ± 0.09 NS NS
5 5.2 × 101 NS *0.30 ± 0.08 NS
24 6.5 × 102 NS NS NS
DT6/non-O157 STEC (ARG4827) 5 2.4 × 104 *0.33 ± 0.09 *0.47 ± 0.12 *0.56 ± 0.17
24 4.0 × 102 *0.43 ± 0.13 NS NS
5 2.4 × 103 NS *0.37 ± 0.09 *0.50 ± 0.16
24 4.0 × 101 *0.35 ± 0.11 NS NS
DT6/O157:H7 STEC (464) 5 2.3 × 103 *0.59 ± 0.16 **0.86 ± 0.15 *0.38 ± 0.10
24 5.8 × 103 **0.77 ± 0.14 ***1.15 ± 0.12 NS
5 2.3 × 102 *0.38 ± 0.09 *0.62 ± 0.18 NS
24 5.8 × 102 NS **0.74 ± 0.13 NS
Cocktail/DH5α 5 2.25 × 104 *0.91 ± 0.19 **2.16 ± 0.20 **2.23 ± 0.21
24 1.75 × 104 *0.66 ± 0.15 NS NS
Cocktail/O157:H7 STEC (464) 5 1.56 × 105 NS NS NS
24 3.33 × 105 **1.43 ± 0.24 **2.58 ± 0.21 **2.20 ± 0.22
MOI, multiplicity of infection (PFU/CFU); NS, not significant. Mean values of treated and control samples not significantly different using the scheffé method
(*significant at p = 0.05; **significant at p = 0.01; ***significant at p = 0.001).
aLog reduction in E. coli viable cells with respect to phage-free control.
bMean of three data points ± standard deviations.
(A600 = 0.2 − 0.3) of each presumptive BIM in Hershey broth
was infected with the phage suspension at various MOI (≈ 10
and 1). Uninfected cultures of each E. coli strain were used
as controls. BIMs cultures were incubated in Hershey broth
at 37◦C until growth of control strains was evident. Infected
cultures that did not lyse at the first attempt were subcul-
tured again. Each second subculture was prepared by trans-
ferring 2–3% of the final volume from the first culture to
another test tube with 1mL of fresh broth. When no bacte-
rial lysis was evident, the resulting culture was stored at 4◦C
and subcultured under the same conditions. Presumptive BIMs
that survived the third subculture were considered to be con-
firmed BIMs. Sensitivity of each parent strain (sensitive) was
always determined in parallel to ensure lytic activity of phage
suspensions.
DETERMINATION OF BACTERIOPHAGE-INSENSITIVE MUTANT
FREQUENCY, REVERSION, AND STABILITY
The emergence frequency of BIMs was evaluated by mixing
the appropriate volume of an overnight culture of each strain
(EPEC920 and O157:H7 STEC 464) and phage suspension (DT1
and DT6) to obtain a MOI of 100. The bacterium–phage
mixture was supplemented with MgSO4 (5mM), plated by the
double-layer agar technique and incubated overnight at 37◦C.
BIM frequency was estimated as the ratio of the number of con-
firmed BIM to the initial bacterial number. All the experiments
were performed in duplicate. Selected BIMs were propagated
through 50 generations at 37◦C and then checked by a plaque
assay to evaluate reversion to phage sensitivity (O’Flynn et al.,
2004).
Phage resistance stability was assayed by seven sequential sub-
cultures of 2% portions of BIM cultures (Hershey broth) with
independent addition of phage at each subculture (Guglielmotti
et al., 2007). The loss of phage resistance was determined by
comparing lysis of BIM culture with the control (mutant sub-
culture without phage addition). The subculture where lysis first
occurred was recorded.
STATISTICAL ANALYSIS
Means and standard deviations for data sets were calculated.
Differences between means for control (untreated) and treated
samples were compared by the Scheffé method and Origin 6.0
for graphics. Differences were considered statistically significant
when p-values were <0.05.
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RESULTS
ISOLATION, VIABILITY, AND CHARACTERISTICS OF BACTERIOPHAGE
STOCKS
A total of 10 bacteriophage stocks were obtained from diarrheic
stool samples, titred and stored at 4◦C. Figure 1 shows plaques
produced by DT1 and DT6 on the EPEC920 and O157:H7 STEC
strains. Phage concentration ranged between 1.2 × 1010 PFU/mL
and 4.8 × 1010 PFU/mL. The viability of each bacteriophage stock
stored at 4◦C was evaluated after two months and similar titers
were obtained, suggesting that the storage method used was
adequate. Electronic microscopy allowed us to infer that bacte-
riophages DT1 and DT6, could taxonomically belong to T-even
type of the Myoviridae family. Phages DT1 and DT6 had icosahe-
dral heads and contractile tails. DT1 dimensions were of 89.3 nm
(head diameter), 127.8 nm (tail length), 20.8 nm (tail thickness),
and a total length of 217.1 nm; for DT6measures were of 82.1 nm
(head diameter), 125.7 nm (tail length), 17.7 nm (tail thickness),
and 207.8 nm (total length) (Figure 2). PCR determinations of
virulence factors (Stx1; Stx2; ST1; LT1 and Intimin) were negative
for all bacteriophage stocks.
FIGURE 1 | Plaques produced by DT1 and DT6 on EPEC920 (A and B,
respectively) and O157:H7 STEC strains (C and D, respectively). Bars
represent 1 cm.
FIGURE 2 | Electron micrograph of phages DT1 (A) and DT6 (B)
negatively stained with 2% phosphotungstic acid. Dimensions are given
in the text. Bars represent 100 nm.
BACTERIOPHAGE SPECIFICITY
Non-E. coli and non-pathogenic E. coli strains were resistant to the
lytic action of phages. Among the pathogenic E. coli, six (6) E. coli
O157:H7 STEC, three (3) non-O157 STEC, five (5) EPEC, and
two (2) UPEC strains were sensitive to phages evaluated (Table 4).
BIOCONTROL TESTS ON MEAT PRODUCTS
Two bacteriophages, which formed clearly defined plaques, with
different host range were selected. The phage with the narrower
range (DT1) was tested on an EPEC strain while the phage with
the broader range (DT6) was tested on the same EPEC strain
assayed previously and two STEC strains, one O157:H7 and one
non-O157.
Significant decreases (p = 0.05) in viable cells (VC) for all
tested strains were observed in comparison to the phage-free con-
trols. Table 3 shows log VC significant reductions (p < 0.05) at
high MOI in EPEC920, non-O157 STEC and O157:H7 STEC
strain/DT6 systems after 3-h incubation, and in all phage/strain
systems after 6-h incubation at 5◦C. At high MOI values, VC
reduction were still significant (p = 0.05) after 24 h of DT6 phage
exposure. When the test was carried out at 24◦C, significant VC
reduction (p < 0.05) were observed after 3 h for DT1/EPEC920,
DT6/O157:H7 STEC, DT6/EPEC920, and DT6/non-O157 STEC.
These reductions were not maintained after 6 or 24 h, with the
exception of the 1.15 log reduction obtained for DT6/O157:H7
STEC after 6 h.
When the results obtained with different MOIs were
compared, significant differences (p = 0.05) at both tempera-
tures were observed for most phages/bacterium combinations.
Reductions in a phage/bacterium system were higher at the high-
est temperature, up to 0.29 log (1.15 log – 0.86 log) CFU for
Table 4 | Host range of stock phages.
Phage stock E. coli sensitive strains Total sensitive
strains
DT1 2 EPEC; 1 O157:H7 STEC;
1 non-O157 STEC
4
DT2 2 EPEC; 3 O157:H7 STEC 5
DT3 4 EPEC; 6 O157:H7 STEC;
3 non-O157 STEC
13
DT4 4 EPEC; 5 O157:H7 STEC;
3 non-O157 STEC
12
DT5 2 EPEC; 3 O157:H7 STEC 5
DT6 4 EPEC; 6 O157:H7 STEC;
3 non-O157 STEC
13
LM1 2 EPEC; 4 O157:H7 STEC;
1 non-O157 STEC
7
LM2 1 EPEC; 1 O157:H7 STEC;
2 non-O157 STEC
4
LM3 2 EPEC; 3 O157:H7 STEC;
2 non-O157 STEC; 1 UPEC
8
LM4 1 EPEC; 2 O157:H7 STEC;
2 non-O157 STEC; 1 UPEC
6
EPEC, enteropathogenic E. coli; O157:H7 STEC, O157:H7 Shigatoxigenic E. coli;
non-O157 STEC, Shigatoxigenic non-O157 E. coli; UPEC, uropathogenic E. coli.
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DT6/O157:H7 STEC at 6 h, with exception in a single case for the
DT6/EPEC920 system, after 3-h incubation.
Phage stocks displayed different host range (Table 4), some
having limited and others having a broader range. The lytic abil-
ity of phages at different MOI values and temperatures is shown
in Figure 3. The biocontrol effectiveness against EPEC920 shown
by DT1 (Figures 3A,B) and DT6 (Figures 3C,D) phages was dif-
ferent only at the lower temperature. At 5◦C, DT1 produced a
greater reduction in the number of VC after 6-h incubation than
DT6, but DT6 biocontrol over EPEC920 was faster and pro-
longed. At 24◦C there was no difference in the lytic effects of
phages with the exception at the longer incubation time and lower
MOI (4.8 × 101 PFU/CFU) where DT1 was more effective. DT6
was also active against O157:H7 strains; being more effective at
24◦C (Figure 3F) though with a prolonged lytic action at 5◦C
(Figure 3E).
The phage cocktail successfully reduced DH5αVC only at 5◦C,
while for O157:H7 STEC reductions took place only at 24◦C
(Figure 4). DH5αwas significantly reduced at 3, 6, and 24 h, being
2.23 log the major reduction value obtained at 24 h. For O157:H7
STEC, VC reductions up to 2.58 log at 6 h were observed, in addi-
tion, phage cocktail was able to achieve an effective and prolonged
biocontrol effect (2.20 log at 24 h) (Table 3).
ISOLATION AND REVERSION OF BIMs
After incubating meat inoculated with phage/bacteria systems at
24◦C for 24 h, significant bacterial growth was observed. To assess
whether bacterial re-growth on meat experiments may be due
to resistance, eight (8) potential BIMs were isolated from meat
incubated for 48 h at 37◦C and only 2 (25%) were confirmed as
BIMs by the liquid culture sensitivity test method. Another eight
(8) presumptive BIMs were isolated by the secondary culture
method and 6 (75%) were confirmed. BIM frequencies observed
for all the evaluated strains were low, ranging from 6.5 × 10−7 to
1.8 × 10−6 (Table 5).
One BIM, which could form a lawn, was found to be suscep-
tible to phage DT6. BIMs evaluated for phage DT1 were resistant
and showed no reversion to phage sensitivity. Mutants isolated
from EPEC920maintained their phenotype up to the fifth subcul-
ture. Mutants isolated fromO157:H7 STECmaintained resistance
up to the fourth subculture and only one was resistant at the
seventh subculture.
DISCUSSION
Biocontrol by bacteriophages in meat products was developed
in the last years and their recent “generally recognized as safe”
(GRAS) designation and approval as food additives (FDA, 2006)
has opened the discussion about “edible virus.” Phages are
naturally present in significant numbers in water and food
(Sulakvelidze, 2011). In fresh meats andmeat products more than
108 viable bacteriophages per grammay be present (Kennedy and
Bitton, 1987), implying that phages are commonly consumed in
large numbers. In addition, bacteriophages are especially abun-
dant in the gastrointestinal tract (Breitbart et al., 2003; Hitch
et al., 2004). However, most phage-host systems are highly spe-
cific, which is a general limitation (Carlton et al., 2005). Phage
must be lytic and non-transducing as minimum requirements to
ensure safety (Greer, 2005). Nevertheless, application of bacterio-
phages is a non-destructive, natural, self-perpetuating biocontrol
method and can be as efficient as chemical agents for controlling
specific bacterial pathogens (Leverentz et al., 2001). On the other
hand, the high specificity of phages allows direct application onto
a product or the possibility to use bacteriophages as “food addi-
tives,” mixing themwith foods without affecting their quality (Jay,
1996), hygiene and other normal microbiota viability of the food
(Kudva et al., 1999) or the consumers’ (Chibani-Chennoufi et al.,
2004).
Previous studies have demonstrated the feasibility of isolating
phages that specifically lyse O157:H7 E. coli strains (Sulakvelidze
and Barrow, 2005; Raya et al., 2006). O’Flynn et al. (2004) devel-
oped a three-phage cocktail that was effective for reducing the
numbers of E. coliO157:H7 onmeat products. On the other hand,
in a similar experiment, Dykes and Moorehead (2002) found
no effect of bacteriophage for control of Listeria monocytogenes
development on contaminated beef, however, this treatment did
not yield an appreciable reduction due to the low MOI used.
Also, phage-mediated reductions of bacterial cell viability have
been reported in various food matrices like contaminated melon
(Leverentz et al., 2003) and cheese (Carlton et al., 2005; Bueno
et al., 2012).
Phages isolated in this study were characterized by their host
range, electron microscopy (DT1 and DT6), and PCR analysis.
The host range evaluation demonstrated that all O157:H7 strains,
most non-O157 STEC and some EPEC isolated from diarrheic
faeces or food, were sensitive to one or several bacteriophages.
In contrast, no nonpathogenic strain was affected. These find-
ing suggest the possibility of using phages for food conservation
without altering the gastrointestinal tract normal microbiota.
However, a broader host range needs to be assessed to ensure
safety for commensal bacteria. Phages did not contain genes
encoding stx1, stx2, eaeA, LT1 and ST1, but other virulence factors
and phage-encoded genes may contribute to bacterial virulence,
so further sequencing and bioinformatic analysis are required to
ensure they are benign prior to their use as biocontrol tools.
DT1 and DT6 on meat, gave statistically significant VC reduc-
tions, comparable to those previously reported (O’Flynn et al.,
2004). EPEC920 was tested with both phages individually; at
5◦C DT6 produces a minor reduction in VC count but a rapid
and prolonged effect in time. This observation may be related to
different adsorption rate and lysis time distinctively influenced
by environmental conditions (Shao and Wang, 2008). Higher
reductions were observed (for O157:H7 STEC) at the higher tem-
perature (24◦C), probably due to the active growth of bacteria
allowing an efficient bacteriophage replication. Similar results at
5 and 24◦C for Salmonella and Campylobacter were described by
Bigwood et al. (2008). The biocontrol effect for all phages ana-
lyzed was found to be dose-dependent, with the highest phage
concentration being the most effective, as was also found by
Leverentz et al. (2001). Our findings showed that phage-bacteria
interaction on meat surfaces was significantly influenced by the
initial number of inoculated phage and bacteria. Atterbury et al.
(2003) obtained marginal reductions of approximately 1 log CFU
only with high initial bacterial density of C. jejuni (4–6 log
CFU). The requirements for a relatively high threshold density
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FIGURE 3 | Comparison of the lytic ability of phages at different
MOI and temperatures. Symbols represent phage free controls ( ),
low MOI (•), and high MOI (). Cell count (CFU/mL) using as matrix
inoculated meat with DT1/EPEC920 at 5◦C (A) and 24◦C (B),
DT6/EPEC920 at 5◦C (C) and 24◦C (D) and DT6/O157:H7 STEC at 5◦C
(E) and 24◦C (F).
of bacterial host cells may limit the impact of phages on bacte-
ria, constituting an important impediment to phage biocontrol
(Greer, 2005). In addition, there are several factors influencing
inactivation on food, the most relevant in our experiments is
the food matrix ability to absorb liquid from the phage sus-
pension. This is a decisive parameter which physically limits
the distribution of phage particles in order to reach all targeted
bacteria. Therefore, decreased effectiveness of these treatments
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FIGURE 4 | E. coli viable cell counts (CFU/mL) in absence (◦) and presence (•) of phages (cocktail) in meat products. Cocktail/DH5α at 5◦C (A),
cocktail/DH5α at 24◦C (B), cocktail/O157:H7 STEC at 5◦C (C), and cocktail/O157:H7 STEC at 24◦C (D) systems.
Table 5 | In vitro and meat BIM isolation and determination of BIM frequency.
Source of BIMs Presumptive BIMs tested Confirmed BIMs (%) BIM frequency (mean ± SD)a
Secondary culture 8 EPEC 6 (75.0) EPEC/DT1 = 8.7 × 10−7 ± 3.9 × 10−8
EPEC/DT6 = 6.5 × 10−7 ± 4.8 × 10−8
Meat 8 O157:H7 2 (25.0) O157:H7 STEC/DT1 = 1.8 × 10−6 ± 1.5 × 10−7
STEC O157:H7 STEC/DT6 = 1.3 × 10−6 ± 9.4 × 10−7
aSD, standard deviation. Means and SD were calculated from duplicate experiments.
EPEC, enteropathogenic E. coli; O157:H7 STEC: O157:H7 Shigatoxigenic E. coli.
may be partially due to limited diffusion and contact between
bacteria and phage particles. Moreover, targeted bacteria may
be embedded within the rather complex food matrix, thereby
shielding them from phage particles. On these grounds, a greater
biocontrol effect may be achieved by modifying phage applica-
tion, e.g., by using larger liquid volumes to avoid total liquid
absortion. While the results were statistically significant we can-
not ascertain the practical use of these phages individually on
meat products, mainly due to the 1.15 log reduction obtained
at best. However, the phage cocktail (containing DT1 and DT6)
at a higher MOI was able of further reduce viable cell counts of
O157:H7 STEC (464) than individual phages. This indicates that
phages may be of practical value if cocktails contain higher num-
bers of different phages (to reduce BIMs emergence and expand
cocktail host range) and higher MOI values, since others authors
report that working with higher phage concentrations generally
resulted in greater inactivation (Guenther et al., 2009). In addi-
tion, DH5α indicator strain was only significantly reduced at 5◦C,
this reduction may be caused by lysis from without since DH5α
has a shorter lipopolysaccharide (LPS), thereby being more per-
missive and susceptible to this mechanism, while for O157:H7
STEC (464) at 5◦C this mechanism was not observed and
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no reduction was obtained. This may rather be due to the absence
of bacterial growth necessary for phage replication. At 24◦C,
DH5α cell number was not reduced (only after a 3 h of incu-
bation a 0.66 log reduction was observed) and re-growth was
observed. This recovery in cell number may be due to cells escap-
ing phage treatment by limited phage diffusion and a subsequent
multiplication in addition to BIMs emergence.
In our trials we found an increase in VC number after 24 h
at 24◦C, suggesting that there is a potential phage-resistant vari-
ant selection under these testing conditions. Thus, we propose
to analyze the existence of spontaneous bacteriophage-insensitive
mutants (BIMs), naturally present in bacteria, in order to eval-
uate if they could prevent the use of phages to improve food
safety. Other authors have also reported a subsequent bacte-
rial growth during the in vitro challenge test (O’Flynn et al.,
2004). BIMs emergence, which could compromise the efficacy
of a phage treatment, is often associated with point mutations
in genes encoding receptor molecules on the bacterial cell sur-
face and commonly revert to phage sensitivity rapidly (Garcia
et al., 2007). Kudva et al. (1999) propose that low tempera-
tures and absence of bacterial growth favor phage adsorption
and infection. In contrast, higher temperatures, cell growth,
and the potential for phenotypic variability in expression of the
O-antigen favor survival of phage-resistant cells. We were able to
isolate E. coli BIMs from meat assays and, at a higher rate, when
using the secondary culture method. BIMs isolated in this study
were tested to evaluate resistance phenotype stability and rever-
sion. As previously reported for other systems (O’Flynn et al.,
2004), all these BIMs present low emergence frequency, vari-
able stability, and reversion, namely, mutants resistant to phage
DT6 revert while those resistant to DT1 show no reversion to
phage sensitivity. These findings suggest that E. coli BIMs should
not prevent the use of phages as biocontrol tools, mainly due
to the low emergence frequency observed for all phages eval-
uated. In our trials phage cocktail reduced the appearance of
presumptive-BIMs, however, further studies are required in order
to evaluate the optimal conditions allowing the reduction of BIM
emergence such as adding more different phages in the cocktail
mixture.
We have isolated 10 bacteriophages belonging to the T-even
type of the Myoviridae family. Phages isolated in this study
were negative for all the virulence factors assayed and presented
lytic activity for different E. coli virotypes. In addition, all non-
pathogenic strains evaluated were not affected. BIMs isolated by
exposure to DT1 and DT6 showed low emergence frequency and
in in vitro challenge tests VC reductions were highly significant
(up to 6.3 log units) (data not shown). However, on pieces of beef
assayed, reduction obtained with individual phages was low and
the phage cocktail showed greater reductions although lower than
expected.
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